Typically, research for Alzheimer’s therapy development focuses on gathering data from those who already exhibit signs of the disease. This NIH grant will award $750,000 to projects that focus on molecular profiling those who were able to resist Alzheimer’s into their later years in life, despite being at risk of developing the disease.

Learn more and submit your application.

Source: National Institute on Aging